Tiffany Hollinger has accumulated a wealth of experience in program and project management within the biotechnology and pharmaceutical industry. Starting as a Clinical Research Coordinator at Dana-Farber Cancer Institute, Tiffany has since held various management roles at companies such as Enanta Pharmaceuticals, Broad Institute, Emulate, Inc., and currently at Seres Therapeutics. With a BS in Biological Engineering from Cornell University and an MS in Engineering Management from Tufts University, Tiffany possesses a strong educational background to support their successful career trajectory.
February, 2023 - present
July, 2021
November, 2019